(Q30380902)

21 June 2017

1 reference

title

Pandemic influenza vaccines. (English)

1 reference

21 June 2017

0 references

Lauren J DiMenna

1

1 reference

21 June 2017

Hildegund C J Ertl

series ordinal

2

1 reference

21 June 2017

publication date

1 January 2009

1 reference

Current Topics in Microbiology and Immunology

21 June 2017

published in

1 reference

21 June 2017

volume

333

1 reference

21 June 2017

page(s)

291-321

1 reference

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

21 June 2017

cites work

1 reference

12 December 2020

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

1 reference

12 December 2020

Vaccines for preventing influenza in healthy adults

1 reference

12 December 2020

Ecology and epidemiology of avian influenza in North and South America.

1 reference

12 December 2020

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

12 December 2020

The Generation of 'Cytotoxic' Macrophages in Mice during Infection with Influenza A or Sendai Virus

1 reference

12 December 2020

A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission

1 reference

12 December 2020

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

1 reference

12 December 2020

CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

1 reference

12 December 2020

1 reference

12 December 2020

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast

1 reference

12 December 2020

Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza

1 reference

12 December 2020

Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus

1 reference

12 December 2020

Influenza pandemics of the 20th century

1 reference

12 December 2020

Transient resistance of influenza virus to interferon action attributed to random multiple packaging and activity of NS genes

1 reference

12 December 2020

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

1 reference

12 December 2020

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

1 reference

12 December 2020

Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review

1 reference

12 December 2020

Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.

1 reference

12 December 2020

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

12 December 2020

The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses

1 reference

12 December 2020

A homogeneous population of lymphokine-activated killer (LAK) cells is incapable of killing virus-, bacteria-, or parasite-infected macrophages

1 reference

12 December 2020

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

12 December 2020

Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses

1 reference

12 December 2020

Serologic and genetic characterization of North American H3N2 swine influenza A viruses

1 reference

12 December 2020

Assessment of the anti-viral effect of a short-term oral treatment of mice with live Saccharomyces cerevisiae cells

1 reference

12 December 2020

Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.

1 reference

12 December 2020

Modified M2 proteins produce heterotypic immunity against influenza A virus.

1 reference

12 December 2020

Vaccines for preventing influenza in the elderly

1 reference

12 December 2020

Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes

1 reference

12 December 2020

Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice

1 reference

12 December 2020

1 reference

12 December 2020

Isolation of avian influenza A(H5N1) viruses from humans--Hong Kong, May-December 1997.

1 reference

12 December 2020

Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics

1 reference

12 December 2020

Human illness from avian influenza H7N3, British Columbia

1 reference

12 December 2020

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

1 reference

12 December 2020

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

1 reference

12 December 2020

A case–control study of elderly patients with acute respiratory illness: Effect of influenza vaccination on admission to hospital in winter 2003–2004

1 reference

12 December 2020

The immune system in the elderly: II. Specific cellular immunity.

1 reference

12 December 2020

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

1 reference

12 December 2020

Production of Interferon in Volunteers Infected with Asian Influenza

1 reference

12 December 2020

In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding

1 reference

12 December 2020

Pneumonia in the very old

1 reference

12 December 2020

Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines

1 reference

12 December 2020

The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses

1 reference

12 December 2020

Transmissibility of swine flu at Fort Dix, 1976.

1 reference

12 December 2020

Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.

1 reference

12 December 2020

The genesis of a pandemic influenza virus.

1 reference

12 December 2020

Avian influenza H5N1 in tigers and leopards

1 reference

12 December 2020

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

1 reference

12 December 2020

Cleavage of influenza A virus H1 hemagglutinin by swine respiratory bacterial proteases

1 reference

12 December 2020

Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus

1 reference

12 December 2020

A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus

1 reference

12 December 2020

The Recovery of Mice from Influenza Virus Infection: Adoptive Transfer of Immunity with Immune T Lymphocytes

1 reference

12 December 2020

Monovalent Asian influenza vaccine: evaluation of its use during two waves of epidemic Asian influenza in partly immunized penitentiary population

1 reference

12 December 2020

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

12 December 2020

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children

1 reference

12 December 2020

Avian influenza A (H5N1) in 10 patients in Vietnam

1 reference

12 December 2020

Impact of quarantine on the 2003 SARS outbreak: a retrospective modeling study.

1 reference

12 December 2020

Immunoprophylactic strategies against respiratory influenza virus infection

1 reference

12 December 2020

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

1 reference

12 December 2020

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

1 reference

12 December 2020

Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes

1 reference

12 December 2020

T cell responses to influenza virus infection: effector and memory cells

1 reference

12 December 2020

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain

1 reference

12 December 2020

Lethal H5N1 influenza viruses escape host anti-viral cytokine responses

1 reference

12 December 2020

Therapeutic options for the management of influenza

1 reference

12 December 2020

Protection from lethal influenza virus challenge by oral type 1 interferon.

1 reference

12 December 2020

Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness

1 reference

12 December 2020

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

1 reference

12 December 2020

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

1 reference

12 December 2020

Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge

1 reference

12 December 2020

Pandemic influenza in 1957; review of international spread of new Asian strain

1 reference

12 December 2020

The immune system in the elderly: III. Innate immunity

1 reference

12 December 2020

The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection.

1 reference

12 December 2020

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

1 reference

12 December 2020

PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA B.

1 reference

12 December 2020

Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus

1 reference

12 December 2020

Avian influenza in North and South America, 2002-2005.

1 reference

12 December 2020

1 reference

12 December 2020

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

1 reference

12 December 2020

Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design.

1 reference

12 December 2020

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

12 December 2020

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

1 reference

12 December 2020

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

1 reference

12 December 2020

Origin and progress of the 1968-69 Hong Kong influenza epidemic

1 reference

12 December 2020

Immunosenescence: a review

1 reference

12 December 2020

Passive transfer of local immunity to influenza virus infection by IgA antibody

1 reference

12 December 2020

The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality

1 reference

12 December 2020

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

1 reference

12 December 2020

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

1 reference

12 December 2020

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

1 reference

12 December 2020

Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic.

1 reference

12 December 2020

Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization

1 reference

12 December 2020

Genetic analysis of influenza A virus (H5N1) derived from domestic cat and dog in Thailand

1 reference

12 December 2020

Vaccines for preventing influenza in healthy children

1 reference

12 December 2020

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

1 reference

12 December 2020

NK and NK/T cells in human senescence

1 reference

12 December 2020

Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.

1 reference

12 December 2020

Protective Effect of Vaccination Against Induced Influenza A

1 reference

12 December 2020

Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.

1 reference

12 December 2020

Effectiveness of influenza vaccines during an epidemic of Asian influenza

1 reference

12 December 2020

Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan

1 reference

12 December 2020

A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus

1 reference

12 December 2020

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

1 reference

12 December 2020

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

1 reference

12 December 2020

Effectiveness of influenza vaccine in the community-dwelling elderly

1 reference

12 December 2020

Practical problems in controlling H5N1 high pathogenicity avian influenza at village level in Vietnam and introduction of biosecurity measures

1 reference

12 December 2020

Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus

1 reference

12 December 2020

Follicular dendritic cells in aging, a "bottle-neck" in the humoral immune response

1 reference

12 December 2020

A PCR based method for the identification of equine influenza virus from clinical samples

1 reference

12 December 2020

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

1 reference

12 December 2020

Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection

1 reference

12 December 2020

CD8 T cells and aging

1 reference

12 December 2020

Innate imprinting by the modified heat-labile toxin of Escherichia coli (LTK63) provides generic protection against lung infectious disease

1 reference

12 December 2020

Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus

1 reference

12 December 2020

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

1 reference

12 December 2020

Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly

1 reference

12 December 2020

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

12 December 2020

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

12 December 2020

Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza.

1 reference

12 December 2020

Insights into the interaction between influenza virus and pneumococcus

1 reference

12 December 2020

Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice

1 reference

12 December 2020

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

12 December 2020

Defense mechanisms against influenza virus infection in the respiratory tract mucosa.

1 reference

12 December 2020

Mass mortality of harbor seals: pneumonia associated with influenza A virus

1 reference

12 December 2020

Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens

1 reference

12 December 2020

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

1 reference

12 December 2020

Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model

1 reference

12 December 2020

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice

1 reference

12 December 2020

Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies

1 reference

12 December 2020

The immune system in the elderly: I. Specific humoral immunity

1 reference

12 December 2020

TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses

1 reference

12 December 2020

Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein

1 reference

12 December 2020

Immunosenescence and germinal center reaction

1 reference

12 December 2020

Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants

1 reference

12 December 2020

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

1 reference

12 December 2020

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

12 December 2020

Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

1 reference

12 December 2020

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice

1 reference

12 December 2020

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines

1 reference

12 December 2020

10.1007/978-3-540-92165-3_15

Identifiers

DOI

1 reference

21 June 2017

1 reference